Francesco Belfiore, Elena Napoli, and Luigi Lo Vecchio
In each of 10 highly hyperglycemic decompensated diabetics with ketoacidosis, we found a markedly increased serum activity of two lysosomal hydrolases (N-acetyl--glucosaminidase and -glucuronidase). This was also true to a lesser degree of five diabetics with less severe decompensation and without ketoacidosis. The activity of both enzymes and the degree of hyperglycemia were highly correlated. We think these enzymatic changes result from a process of activation and release of tissue lysosomal enzymes, probably occurring in connection with the increased catabolism present in decompensated diabetes. Nonlysosomal (cytoplasmic or mitochondrial) enzymes were less changed (aspartate and alanine aminotransferases) or normal (aldolase, lactate-and malate dehydrogenase, and creatine kinase). This indicates that tissue damage alone could not account for the increased activity of the two lysosomal hyd rolases; it therefore seems primarily to be due to involvement of lysosomes. N-acetyl- showed that these patients were free from diseases other than diabetes. Besides the more usual investigations-such as the determination of glycemia, glycosuria, azotemia, ketone bodies, and plasma electrolytes-several serum enzymatic activities were measured. In ketoacidotic patients, enzyme activities were first measured at about the 12th hour from the onset of mental clouding, and then repeated at about the 36th, 60th, 84th, 108th, and 132nd hours as shown in Figure  1 . Enzyme studies were also done on a group of normal subjects, as indicated in Table 1 
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Materials and Methods
Results
Results for the ketoacidotic patients are summarized in Table 1 and in Figures  1 and 2 . At about the 12th hour from the onset of mental clouding, of the enzymes studied, N-acetyl-3-glucosaminidase and 3-glucuronidase activities showed statistically very significant (P < 0.001) increase, with a variation of 140 and 283%, respectively.
Aspartateand alanine aminotransf erase were increased by 54 and 44%, respectively, while the other enzymes changed only insignificantly (Table 1) . N-acetyl-3-glucosaminidase and 3-glucuronidase values did not overlap the normal ones, all values being above the upper normal limit, while for the aminotransf erases, although the mean was appreciably increased, only two values were above the upper normal limit. As regards the other enzymes, values were in all instances within the normal range ( After the first 24 h the patients were no longer ketoacidotic nor hyperglycemic, since, within some hours of admission, metabolic compensation was achieved by appropriate treatment. In fact, mean blood glucose values in mg per 100 ml (± SD) were 640 (±209) at about the 12th hour from 'the onset of mental clouding, 168 (±96) at the 36th hour, 159 (±74) ml at the 60th hour, 149 (± 34) at the 84th hour, 120 (±14) at the 108th hour and 129 (±22) at the 132nd hour. However, serum enzyme activities were followed for several days, and we saw a rapid decrease in the activity of N-acetyl-$-glucosamiidase and 3-glucuronidase ( Figure  1 ), while the other enzymes showed moderate irregular variations. Glycemia was statistically significantly correlated with N-acetyl-3-glucosaminidase (r = 0.774, P < 0.01) and f3-glucuronidase (r = 0.668, P < 0.01), but not with the other enzymes investigated (P ranging between 0.10 and 0.50). Correlation with azotemia, ketone bodies, or plasma electrolytes was not significant for any of the enzymes studied.
The transaminases were elevated in only two patients with marked tachycardia, severely subnormal blood pressure, and liver enlargement. In these two subjects N-acetyl-fl-glucosaminidase and 3-glucuronidase activities were not higher than in the other patients. Figure 2 refers to a patient who had a relapse at about the 60th hour from the onset of mental clouding, and shows the close correlation of both N-acetyl-3-glucosaminidase and 3-glucuronidase with glycemia, as well as the different behavior of these two enzymes from that of aspartate aminotransf erase. In the five decompensated diabetics without ketoacidosis we found an average value of 12.16 ± 2.40 U for N-acetyl-3-glucosaminidase and of 818 ± 270 U for -glucuronidase.
These values, compared to normal, were increased by 80 and 140%, respectively. Therefore, these diabetics had more moderate hyperglycemia compared to the ketoacidotic patients, and comparatively less accentuated increase in enzyme activity. The other enzymes investigated were within the normal range in these five subjects.
In five normal sera with an average value of 5.80 ± 1.18 U for Nacetyl-3-glucosaminidase and of 302 ± 118 U for fl-glucuronidase, determinations of these enzymes were repeated after addition of glucose to bring the glucose concentration to about 600 mg/100 ml, and a mean of 6.00 ± 1.26 U and 298 ± 129 U, respectively, was found for the two enzymes. This shows that hyperglycemia itself does not affect the activity of these enzymes.
Discussion
The results described above raise the problem of interpreting an observed marked elevation of serum N-acety1-3-glucosaminidase and f3-glucuronidase, with less pronounced and inconstant changes of transaminases and only minor va.riations of other enzymes, in a complex condition such as decompensated diabetes. Since in our patients the activity of both Nacetyl-3-glucosaminidase and 3-glucuronidase was correlated with glycemia, and promptly returned towards normal as metabolic compensation was achieved, the increased activity was clearly linked to the acute condition of severe diabetic decompensation.
Therefore, this enzymatic change cannot be ascribed, as it has been, to a possible underlying chronic liver involvement (10) or to the increased susceptibility of diabetics to atherosclerosis (3, 4) .
It seems that even the possibility of acute involvement of some organ being the cause of serum elevation of these two enzymes can be excluded, because, if this were so, the most pronounced changes should be in other enzymes-such as, for instance, the transaminases in the case of involvement of liver, or creatine kinase in the case of involvement of muscle. In fact, with the possible exception of some forms of chronic liver diseases (7, 9), available data (7) (8) (9) 24) se does not seem to play a significant role, since both N-acetyl-$-glucosaminidase and $-glucuronidase were increased also in decompensated diabetics without ketoacidosis. Which tissue is the major source of N-acetyl-j3-glucosaminidase and f3-glucuronidase in severe diabetes cannot be established with certainty. In man, the highest activity of these enzymes has been found in the thymus, liver, spleen, and adrenal gland (32). Of these organs, the liver, both because of its size and its metabolic importancewhich causes it to be greatly involved in diabetic decompensation-appears to be the most probable source of lysosomal enzymes in serum.
